PRLB
Get informed when a big investor buys or sells
+ FollowOvervalued by 71.5% based on the discounted cash flow analysis.
| Market cap | $2.09 Billion |
|---|---|
| Enterprise Value | $1.96 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.89 |
| Beta | 1.42 |
| Outstanding Shares | 23,902,802 |
| P/E Ratio | 69.09 |
|---|---|
| PEG | 64.74 |
| Price to Sales | 4.04 |
| Price to Book Ratio | 3.32 |
| Enterprise Value to Revenue | 3.5 |
| Enterprise Value to EBIT | 51.57 |
| Enterprise Value to Net Income | 64 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1200▲ 12.00% |
|---|---|
| Total Calls | 30,000▼ 78.57% |
| Total Puts | 3,600▲ Infinity% |
Holdings and activity of institutional investors.
| Ownership % | 95.46%▲ 2.76% |
|---|---|
| Total Invested | $1.86B▲ 47.52% |
| Investors Holding | 282▲ 15.00% |
No data
Protolabs is a company that provides rapid manufacturing of low-volume 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and short-run production. Markets like medical devices, electronics, applianc...